Xbrane is hosting a Virtual Capital Markets Day on May 17th, 2021

Corporate Information





Stockholm, Sweden – Xbrane (Nasdaq: XBRANE), a late-stage clinical biopharma company is inviting analysts, investors and media to the company’s Virtual Capital Markets Day on May 17th, 2021 at 14.00-15.30 CET.

The event will feature presentations from Xbrane’s Board and Management team outlining the company strategy and the next steps in the company's ambition to become a leading global biosimilar developer. The program will also include a virtual show of the recently established new development lab.

The event will start at 14.00 and will be broadcast live.

Please register using the following link;


Xbrane Biopharma Anders Tullgren, Chairman
The Biosimilar Market Martin Åmark, CEO
Xlucane™ Martin Åmark, CEO
Platform Technology & Capabilities David Vikström, Head of R&D
Virtual tour of the new Biotech lab Siavash Bashiri, Deputy CEO
A world-leading Biosimilar Developer Martin Åmark, CEO
Wrap-up and Q&A session Martin Åmark, CEO

Agenda in brief:

Participants are invited to ask questions to IR@xbrane.com or live during the event.

Recordings of the presentations, and the presentations themselves, will be made available on the website www.xbrane.com.